Keywords: مهار کننده نورامینیداز; Influenza; Laninamivir; Neuraminidase inhibitor; Fever; Symptom;
مقالات ISI مهار کننده نورامینیداز (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: مهار کننده نورامینیداز; Influenza; Laninamivir; Neuraminidase inhibitor; Fever; Symptom;
Keywords: مهار کننده نورامینیداز; Aging; Antiviral drugs; Geriatrics; Gerontology; High-risk patient; Neuraminidase inhibitor;
Keywords: مهار کننده نورامینیداز; Respiratory virus; Influenza; Respiratory syncytial virus (RSV); Neuraminidase inhibitor; Ribavirin;
Keywords: مهار کننده نورامینیداز; Influenza; Laninamivir; Neuraminidase inhibitor; Fever; Symptom
Keywords: مهار کننده نورامینیداز; Influenza; Neuraminidase inhibitor; Michael reaction; Wittig reaction; Organocatalyst;
Keywords: مهار کننده نورامینیداز; Laninamivir; Influenza; Powder delivery; Ferrets; Antiviral; Neuraminidase inhibitor;
Keywords: مهار کننده نورامینیداز; NA; neuraminidase; NAI; neuraminidase inhibitor; IC50; drug concentration which reduces enzyme activity by 50% compared to untreated enzyme; Influenza; Neuraminidase inhibitors; Reactivation; Drug resistance; Mutants;
Keywords: مهار کننده نورامینیداز; Influenza; Household secondary infection; Neuraminidase inhibitor; Health-insurance claims data
Keywords: مهار کننده نورامینیداز; COPD; chronic obstructive pulmonary disease; IL; interleukin; DPB; diffuse panbronchiolitis; NSAID; non-steroidal anti-inflammatory drug; Clarithromycin; Fever; Inflammation; Influenza; Neuraminidase inhibitor;
Keywords: مهار کننده نورامینیداز; MDCK; Madin-Darby canine kidney; FBS; fetal bovine serum; PBS; phosphate buffered saline; BSA; bovine serum albumin; pfu; plaque forming unit; MLD50; 50% mouse lethal dose; hpi; hours postinfection; dpi; days postinfection; MRT; mean residence time; hal
Keywords: مهار کننده نورامینیداز; CNRL; Community Network of Reference Laboratories for Human Influenza in Europe; ECDC; European Centre for Disease Prevention and Control; EEA; European Economic Area; EISN; European Influenza Surveillance Network; EQA; External Quality Assessment; EU; Eu
Keywords: مهار کننده نورامینیداز; Laninamivir; Neuraminidase inhibitor; Influenza; Prophylaxis; Post-exposure; Household contact;
In vitro neuraminidase inhibitory concentration (IC50) of four neuraminidase inhibitors in the Japanese 2016-17 season: Comparison with the 2010-11 to 2015-16 seasons
Keywords: مهار کننده نورامینیداز; Influenza virus; Neuraminidase inhibitor; 50% inhibitory concentration; Resistance; Surveillance;
Identification of Indonesian clade 2.1 highly pathogenic influenza A(H5N1) viruses with N294S and S246N neuraminidase substitutions which further reduce oseltamivir susceptibility
Keywords: مهار کننده نورامینیداز; Avian influenza; H5N1; Surveillance; Oseltamivir; Neuraminidase inhibitor; Resistance;
Screening and isolation of potential neuraminidase inhibitors from leaves of Ligustrum lucidum Ait. based on ultrafiltration, LC/MS, and online extraction-separation methods
Keywords: مهار کننده نورامینیداز; Ligustrum lucidum; Neuraminidase inhibitor; Ultrafiltration; Pressurized liquid extraction; Centrifugal partition chromatography; Preparative liquid chromatography;
Susceptibility of Brazilian influenza A(H1N1)pdm09 viruses to neuraminidase inhibitors in the 2014-2016 seasons: Identification of strains bearing mutations associated with reduced inhibition profile
Keywords: مهار کننده نورامینیداز; Influenza; Pyrosequencing; Neuraminidase inhibitor; Oseltamivir; Antiviral; H275Y;
Acylguanidine derivatives of zanamivir and oseltamivir: Potential orally available prodrugs against influenza viruses
Keywords: مهار کننده نورامینیداز; Acylguanidine; Zanamivir; Oseltamivir; Neuraminidase inhibitor; Influenza; Arg; arginine; Boc; tert-butoxycarbonyl; (Boc)2O; di(tert-butyl) dicarbonate; CC50; half maximal cytotoxicity concentration; CPE; cytopathic effect; DIEA; diisopropyl ethylamine; D
Prevention and treatment of respiratory viral infections: Presentations on antivirals, traditional therapies and host-directed interventions at the 5th ISIRV Antiviral Group conference
Keywords: مهار کننده نورامینیداز; Influenza; RSV; Antivirals; Vaccines; Isirv-AVG; ARDS; Acute respiratory distress syndrome; AUC; Area under the curve; CAP; Community acquired pneumonia; HA; hemagglutinin; HPAI; Highly pathogenic avian influenza; LPM; Live poultry markets; MERS-CoV; Midd
Pre-and post-pandemic trends in antiviral use in hospitalized patients with laboratory-confirmed influenza: 2004/05-2013/14, Toronto, Canada
Keywords: مهار کننده نورامینیداز; Influenza; Neuraminidase inhibitor; Post-pandemic; Predictors; Hospital patients; APACHE; acute physiology and chronic health evaluation; CI; confidence interval; DFA; direct fluorescent antigen; EIA; enzyme immunoassay; ICU; intensive care unit; ILI; inf
Isolation, structural characterization and neuraminidase inhibitory activities of polyphenolic constituents from Flos caryophylli
Keywords: مهار کننده نورامینیداز; NA; neuraminidase; HA; haemagglutinin; MUNANA; methylumbelliferyl-α-d-N-acetylneuraminate; MDCK; Madin-Darby canine kidney; MNCC; maximal non-cytotoxic concentration; HHDP; hexahydroxydiphenoyl; MTT; 3-[4,5-dimethyl-thiazol-2-yl]-2,5- diphenyl tetrazoliu
Therapeutic efficacy of peramivir against H5N1 highly pathogenic avian influenza viruses harboring the neuraminidase H275Y mutation
Keywords: مهار کننده نورامینیداز; Influenza; H5N1; HPAI; Peramivir; NAI; Mouse model; HPAI; highly pathogenic avian influenza; NA; neuraminidase; NAI; neuraminidase inhibitor; HK483; A/Hong Kong/483/1997 strain; HK483/H275Y; A/Hong Kong/483/1997 strain with H275Y mutation in NA; MDCK; Mad
Discovery of berberine based derivatives as anti-influenza agent through blocking of neuraminidase
Keywords: مهار کننده نورامینیداز; Antiviral; Influenza; Neuraminidase inhibitor; Berberine derivate;
In vitro neuraminidase inhibitory concentration (IC50) of four neuraminidase inhibitors against clinical isolates of the influenza viruses circulating in the 2010–2011 to 2014–2015 Japanese influenza seasons
Keywords: مهار کننده نورامینیداز; Influenza; Neuraminidase inhibitor; Resistance; A(H3N2); B; IC50
A novel synthetic approach to the racemic Neuraminidase inhibitor Peramivir
Keywords: مهار کننده نورامینیداز; Peramivir; Neuraminidase inhibitor; Bicyclo[2.2.1]hepta-2,5-diene; 1,3-Dipolar cycloaddition;
Assessing the oral bioavailability of difluorosialic acid prodrugs, potent viral neuraminidase inhibitors, using a snapshot PK screening assay
Keywords: مهار کننده نورامینیداز; Neuraminidase inhibitor; Prodrug; Difluorosialic acid; Snapshot PK screen; Bioavailability;
Quantitative analysis of influenza A (H3N2) E119V and R292K variants in clinical specimens by real-time reverse transcription polymerase chain reaction
Keywords: مهار کننده نورامینیداز; NA; neuraminidase; NAI; neuraminidase inhibitor; IC50; 50% inhibitory concentration; RT; reverse transcription; PCR; polymerase chain reaction; WT; wild type; SD; standard deviation; NI; not isolated; NA; not applicable; ND; not determined; Resistant viru
Intravenous peramivir inhibits viral replication, and leads to bacterial clearance and prevention of mortality during murine bacterial co-infection caused by influenza A(H1N1)pdm09 virus and Streptococcus pneumoniae
Keywords: مهار کننده نورامینیداز; Bacterial co-infection; Neuraminidase inhibitor; Peramivir; Influenza virus; Streptococcus pneumoniae;
Influenza A viruses of swine circulating in the United States during 2009-2014 are susceptible to neuraminidase inhibitors but show lineage-dependent resistance to adamantanes
Keywords: مهار کننده نورامینیداز; BCI; Bayesian credibility interval; NA; neuraminidase; NAI; neuraminidase inhibitor; IRAT; Influenza Risk-Assessment Tool; IRD; influenza research database; MDCK; Madin-Darby canine kidney; IAV-S; influenza A virus of swine; TRIG; triple reassortant int
Zanamivir Amidoxime- and N-Hydroxyguanidine-Based Prodrug Approaches to Tackle Poor Oral Bioavailability
Keywords: مهار کننده نورامینیداز; influenza A; neuraminidase inhibitor; synthesis; drug-like properties; prodrug; pharmacokinetics; bioavailability; guanidine bioisoster; amidine
Oseltamivir hydroxamate and acyl sulfonamide derivatives as influenza neuraminidase inhibitors
Keywords: مهار کننده نورامینیداز; Influenza; Neuraminidase inhibitor; Oseltamivir; Bioisosteres; Hydroxamate; Acyl sulfonamide;
Neuraminidase inhibitor susceptibility testing of influenza type B viruses in China during 2010 and 2011 identifies viruses with reduced susceptibility to oseltamivir and zanamivir
Keywords: مهار کننده نورامینیداز; Neuraminidase inhibitor; Zanamivir; Oseltamivir; Influenza B;
Xanthones from Polygala karensium inhibit neuraminidases from influenza A viruses
Keywords: مهار کننده نورامینیداز; Polygala karensium; Xanthone; Influenza A; Novel influenza H1N1; Neuraminidase inhibitor; Oseltamivir resistance
Efficacy of a single intravenous dose of the neuraminidase inhibitor peramivir in the treatment of equine influenza
Keywords: مهار کننده نورامینیداز; Equine influenza; H3N8; Neuraminidase; Neuraminidase inhibitor; Peramivir;
Analysis of influenza viruses from patients clinically suspected of infection with an oseltamivir resistant virus during the 2009 pandemic in the United States
Keywords: مهار کننده نورامینیداز; Pandemic H1N1; Neuraminidase inhibitor; Pyrosequencing; Neuraminidase inhibition assay; H275Y; I223K; I223R
Increased concentration of sialidases by HeLa cells might influence the cytotoxic ability of NK cells
Keywords: مهار کننده نورامینیداز; cervical cancer cell line; cytotoxicity; natural killer cell; neuraminidase; neuraminidase inhibitor; sialidase
Intramolecular ion-pair prodrugs of zanamivir and guanidino-oseltamivir
Keywords: مهار کننده نورامینیداز; Influenza; Neuraminidase inhibitor; Intramolecular ion-pair; Prodrug;
Design, synthesis and biological activity of thiazolidine-4-carboxylic acid derivatives as novel influenza neuraminidase inhibitors
Keywords: مهار کننده نورامینیداز; Neuraminidase inhibitor; Influenza; Thiazolidine; Biological activity
Very low pandemic influenza A (H1N1) 2009 mortality associated with early neuraminidase inhibitor treatment in Japan: Analysis of 1000 hospitalized children
Keywords: مهار کننده نورامینیداز; Influenza; Pandemic influenza A (H1N1) 2009; Neuraminidase inhibitor; Mortality rate; Paediatric inpatients
Widespread use of neuraminidase inhibitors in Japan
Keywords: مهار کننده نورامینیداز; Influenza; Pandemic; Neuraminidase inhibitor; Peramivir; Laninamivir; Oseltamivir; Zanamivir;
Assessment of the efficacy of the neuraminidase inhibitor oseltamivir against 2009 pandemic H1N1 influenza virus in ferrets
Keywords: مهار کننده نورامینیداز; Pandemic 2009 H1N1 virus; Neuraminidase inhibitor; Oseltamivir; Ferret model
Neuraminidase inhibitors for treatment of human and avian strain influenza: A comparative modeling study
Keywords: مهار کننده نورامینیداز; Avian influenza; Neuraminidase inhibitor; Mathematical modeling; Antiviral treatment; Infectious disease;
Oseltamivir, zanamivir and amantadine in the prevention of influenza: A systematic review
Keywords: مهار کننده نورامینیداز; Influenza; Prophylaxis; Prevention; Amantadine; Oseltamivir; Zanamivir; Neuraminidase inhibitor; M2 inhibitor; Systematic review
Neue Influenza A (H1N1) 2009
Keywords: مهار کننده نورامینیداز; Influenza; Schweinegrippe; Flu of swine origin; Mexico-Grippe; Neuraminidase-Hemmer; Influenza-Impfung; Grippe-Impfstoff; Influenza; Swine influenza; Flu of swine origin; Mexico influenza; Neuraminidase inhibitor; Influenza vaccination; Influenza preventi
Impact of oseltamivir treatment on the incidence and course of acute otitis media in children with influenza
Keywords: مهار کننده نورامینیداز; AOM, acute otitis media; CI, confidence interval; ITTI, intent-to-treat infected; LCI, laboratory-confirmed influenza; NI, neuraminidase inhibitor; RR, relative riskInfluenza; Otitis media; Oseltamivir; Neuraminidase inhibitor
Computational design of novel, high-affinity neuraminidase inhibitors for H5N1 avian influenza virus
Keywords: مهار کننده نورامینیداز; H5N1 avian influenza; Neuraminidase inhibitor; Oseltamivir; Molecular dynamics simulation; 150-Cavity;
Analogs of zanamivir with modified C4-substituents as the inhibitors against the group-1 neuraminidases of influenza viruses
Keywords: مهار کننده نورامینیداز; Zanamivir derivative; Neuraminidase inhibitor; Influenza
Quantification of peramivir (a novel anti-influenza drug) in human plasma by hydrophilic interaction chromatography/tandem mass spectrometry
Keywords: مهار کننده نورامینیداز; Hydrophilic interaction chromatography (HILIC); Tandem mass spectrometry; TSK gel Amide-80 column; Peramivir; Neuraminidase inhibitor; Avian influenza;
Neuraminidase inhibitory activities of flavonols isolated from Rhodiola rosea roots and their in vitro anti-influenza viral activities
Keywords: مهار کننده نورامینیداز; Flavonol; Influenza virus; MDCK cell; Neuraminidase inhibitor; Rhodiola rosea
In vitro evaluation of neuraminidase inhibitors using the neuraminidase-dependent release assay of hemagglutinin-pseudotyped viruses
Keywords: مهار کننده نورامینیداز; Neuraminidase inhibitor; Pseudotype virus; Antiviral; Viral release assay; Drug resistance